SCHEMBL6370489

SCHEMBL6370489

Cn1cc(-c2oc(-c3ccc(C(F)(F)F)cc3)nc2C(=O)N[C@@H](COCc2ccccc2)C(=O)O)c2ccccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.39
UGCG Q16739 7/20 0.39
CYP3A4 P08684 6/20 0.39
PTPN1 P18031 3/20 0.38
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PPARA Q07869 3/20 0.37
PPARG P37231 2/20 0.37
PPARD Q03181 1/20 0.36
S1PR1 P21453 1/20 0.36
S1PR3 Q99500 1/20 0.36
FOLH1 Q04609 1/20 0.35
KIFC1 Q9BW19 1/20 0.35
CDK2 P24941 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6370495 1.00 MCL1 (0.39) MCL1UGCGCYP3A4PTPN1KDM4E
SCHEMBL6365738 0.87 ACE (0.42) CYP3A4PTPN1KDM4ENPC1ALDH1A1
SCHEMBL6365732 0.87 ACE (0.42) CYP3A4PTPN1KDM4ENPC1ALDH1A1
SCHEMBL6370499 0.86 PTPN1 (0.44) MCL1UGCGCYP3A4PTPN1PPARA
SCHEMBL6366075 0.86 PTPN1 (0.44) MCL1UGCGCYP3A4PTPN1PPARA
SCHEMBL6366079 0.86 PTPN1 (0.44) MCL1UGCGCYP3A4PTPN1PPARA
SCHEMBL6372140 0.85 FTO (0.42) MCL1PTPN1PPARAPPARGPPARD
SCHEMBL6365967 0.82 UGCG (0.44) MCL1UGCGCYP3A4PTPN1PPARA
SCHEMBL6365959 0.82 UGCG (0.44) MCL1UGCGCYP3A4PTPN1PPARA
SCHEMBL6366531 0.81 MCL1 (0.40) MCL1UGCGCYP3A4PTPN1PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050272784-A1 Inhibitors of bacterial Type III protein secretion systems LI XIAOBING 2005-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272784-A1 Inhibitors of bacterial Type III protein secretion systems GBA3, PSMB3, SEC61B MCL1 3806/4885UGCG 1629/4885CYP3A4 3915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.